Wed, 17 Sep 2014 07:00:00 +0200 Sanofi.com: Last press releases Press releases and press packs are intended to journalists, investors and shareholders. /rss/rss.asp <![CDATA[Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease]]> Wed, 17 Sep 2014 07:00:00 +0200 http://en.sanofi.com/Images/37205_20140917_SanofiMyoKardia_en.pdf <![CDATA[At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies]]> Thu, 11 Sep 2014 07:00:00 +0200 http://en.sanofi.com/Images/37184_20140911_lemtrada_en.pdf <![CDATA[Sanofi successfully prices EUR 3 billion bond issue]]> Thu, 04 Sep 2014 07:00:00 +0200 http://en.sanofi.com/Images/37160_20140904_EURBOND_en.pdf <![CDATA[Sanofi Pasteur’s Dengue Vaccine Candidate Successfully Completes Final Landmark Phase III Clinical Efficacy Study in Latin America]]> Wed, 03 Sep 2014 07:00:00 +0200 http://en.sanofi.com/Images/37154_20140903_DENGUE_en.pdf <![CDATA[Sanofi and Regeneron Present Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014]]> Sun, 31 Aug 2014 09:00:00 +0200 http://en.sanofi.com/Images/37129_20140831_AlirocumabESCDataRelease_en.pdf <![CDATA[Sanofi and Regeneron to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014]]> Mon, 25 Aug 2014 07:00:00 +0200 http://en.sanofi.com/Images/37093_20140825_ESC_PREVIEW2_RELEASE_EN.pdf <![CDATA[FDA Approves Genzyme’s Cerdelga™ (eliglustat) Capsules]]> Tue, 19 Aug 2014 10:45:00 +0200 http://en.sanofi.com/Images/37084_20140819_Cerdelga_US_Approval_en.pdf <![CDATA[Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine]]> Wed, 13 Aug 2014 11:00:00 +0200 http://en.sanofi.com/Images/37069_20140813_Fluzone_High_Dose_NEJM_en.pdf <![CDATA[First antimalarial treatments produced with semisynthetic artemisinin enter market]]> Tue, 12 Aug 2014 01:00:00 +0200 http://en.sanofi.com/Images/37064_20140812_SANOFI_PATH_SSART_MARKET_ENTRY_EN.pdf <![CDATA[Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin]]> Mon, 11 Aug 2014 07:00:00 +0200 http://en.sanofi.com/Images/37059_20140811_Sanofi_MannKind_en.pdf 5 © Sanofi 2004-2014